In this study, three antigenic synthetic peptides, which are overexpressed in several cancer types, were covalently linked with HMGB1-derived peptide (HB100-108) as immunoadjuvant via double R linker and loaded into immature DCs. This evidence concerns the gene HMGB1 and cancer.